Angiogenesis in gliomas: biology and molecular pathophysiology - PubMed (original) (raw)

Review

Angiogenesis in gliomas: biology and molecular pathophysiology

Ingeborg Fischer et al. Brain Pathol. 2005 Oct.

Abstract

Glioblastoma multiforme (GBM) is characterized by exuberant angiogenesis, a key event in tumor growth and progression. The pathologic mechanisms driving this change and the biological behavior of gliomas remain unclear. One mechanism may involve cooption of native blood vessels by glioma cells inducing expression of angiopoietin-2 by endothelial cells. Subsequently, vascular apoptosis and involution leads to necrosis and hypoxia. This in turn induces angiogenesis that is associated with expression of hypoxia-inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF) in perinecrotic pseudopalisading glioma cells. Here we review the molecular and cellular mechanisms implicated in HIF-1-dependent and HIF-1-independent glioma-associated angiogenesis. In GBMs, both tumor hypoxia and genetic alterations commonly occur and act together to induce the expression of HIF-1. The angiogenic response of the tumor to HIF-1 is mediated by HIF-1-regulated target genes leading to the upregulation of several proangiogenic factors such as VEGF and other adaptive response molecules. Understanding the roles of these regulatory processes in tumor neovascularization, tumor growth and progression, and resistance to therapy will ultimately lead to the development of improved antiangiogenic therapies for GBMs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Abdulrauf SI, Edvardsen K, Ho KL, Yang XY, Rock JP, Rosenblum ML (1998) Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low‐grade astrocytoma. J Neurosurg 88:513–520. - PubMed
    1. Abe T, Okamura K, Ono M, Kohno K, Mori T, Hori S, Kuwano M (1993) Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis. J Clin Invest 92:54–61. - PMC - PubMed
    1. Abe T, Terada K, Wakimoto H, Inoue R, Tymin‐ski E, Bookstein R, Basilion JP, Chiocca EA (2003) PTEN decreases in vivo vascularization of experimental gliomas in spite of proangiogenic stimuli. Cancer Res 63:2300–2305. - PubMed
    1. Acker T, Diez‐Juan A, Aragones J, Tjwa M, Brus‐selmans K, Moons L, Fukumura D, Moreno‐Murciano MP, Herbert JM, Burger A, Riedel J, Elvert G, Flamme I, Maxwell PH, Collen D, Dewerchin M, Jain RK, Plate KH, Carmeliet P (2005) Genetic evidence for a tumor suppressor role of HIF‐2alpha. Cancer Cell 8:131–141. - PubMed
    1. Acker T, Plate KH (2002) A role for hypoxia and hypoxia‐inducible transcription factors in tumor physiology. J Mol Med 80:562–575. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources